Analysen zu Hermès (Hermes International)
| 20.09.24 | Hermès Buy | Jefferies & Company Inc. | |
| 20.09.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 10.09.24 | Hermès Outperform | Bernstein Research | |
| 09.09.24 | Hermès Overweight | Barclays Capital | |
| 20.08.24 | Hermès Outperform | Bernstein Research | |
| 02.08.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 30.07.24 | Hermès Overweight | Barclays Capital | |
| 29.07.24 | Hermès Buy | UBS AG | |
| 26.07.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 26.07.24 | Hermès Buy | UBS AG | |
| 15.07.24 | Hermès Buy | UBS AG | |
| 05.07.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 04.07.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 04.07.24 | Hermès Buy | UBS AG | |
| 04.07.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 27.06.24 | Hermès Buy | UBS AG | |
| 19.06.24 | Hermès Outperform | Bernstein Research | |
| 31.05.24 | Hermès Hold | Deutsche Bank AG | |
| 28.05.24 | Hermès Outperform | Bernstein Research | |
| 20.05.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 26.04.24 | Hermès Hold | Deutsche Bank AG | |
| 26.04.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 25.04.24 | Hermès Halten | DZ BANK | |
| 25.04.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 25.04.24 | Hermès Buy | UBS AG | |
| 25.04.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 11.04.24 | Hermès Overweight | Barclays Capital | |
| 10.04.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 09.04.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 02.04.24 | Hermès Buy | UBS AG | |
| 08.03.24 | Hermès Buy | UBS AG | |
| 01.03.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 29.02.24 | Hermès Overweight | Barclays Capital | |
| 13.02.24 | Hermès Halten | DZ BANK | |
| 12.02.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 12.02.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 12.02.24 | Hermès Buy | UBS AG | |
| 09.02.24 | Hermès Buy | UBS AG | |
| 09.02.24 | Hermès Market-Perform | Bernstein Research | |
| 09.02.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 07.02.24 | Hermès Overweight | Morgan Stanley | |
| 19.01.24 | Hermès Buy | UBS AG | |
| 11.01.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 11.01.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 10.01.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 03.01.24 | Hermès Buy | UBS AG | |
| 13.12.23 | Hermès Neutral | JP Morgan Chase & Co. | |
| 07.12.23 | Hermès Hold | Deutsche Bank AG | |
| 01.12.23 | Hermès Market-Perform | Bernstein Research | |
| 21.11.23 | Hermès Buy | UBS AG |
Aktuelle Aktienanalysen
| 06:42 | AB InBev Overweight | JP Morgan Chase & Co. | |
| 06:42 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 06:41 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 06:41 | Unilever Overweight | JP Morgan Chase & Co. | |
| 06:40 | Danone Overweight | JP Morgan Chase & Co. | |
| 06:40 | L'Oréal Neutral | JP Morgan Chase & Co. | |
| 06:39 | QIAGEN Buy | Jefferies & Company Inc. | |
| 06:38 | CTS Eventim Overweight | JP Morgan Chase & Co. | |
| 06:36 | Symrise Overweight | JP Morgan Chase & Co. | |
| 06:35 | Beiersdorf Overweight | JP Morgan Chase & Co. | |
| 06:35 | Nemetschek Underweight | JP Morgan Chase & Co. | |
| 06:33 | Fresenius Medical Care Underweight | JP Morgan Chase & Co. | |
| 06:32 | Stellantis Sector Perform | RBC Capital Markets | |
| 04.11.25 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | Ferrari Outperform | RBC Capital Markets | |
| 04.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 04.11.25 | TRATON Hold | Jefferies & Company Inc. | |
| 04.11.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 04.11.25 | Meta Platforms Kaufen | DZ BANK | |
| 04.11.25 | Nemetschek Verkaufen | DZ BANK | |
| 04.11.25 | BP Kaufen | DZ BANK | |
| 04.11.25 | HUGO BOSS Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | SAF-HOLLAND Kaufen | DZ BANK | |
| 04.11.25 | BP Sector Perform | RBC Capital Markets | |
| 04.11.25 | Ferrari Hold | Jefferies & Company Inc. | |
| 04.11.25 | Linde Kaufen | DZ BANK | |
| 04.11.25 | Raiffeisen | Barclays Capital | |
| 04.11.25 | Ferrari Outperform | Bernstein Research | |
| 04.11.25 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | Ferrari Outperform | RBC Capital Markets | |
| 04.11.25 | Boeing Outperform | RBC Capital Markets | |
| 04.11.25 | Ryanair Overweight | Barclays Capital | |
| 04.11.25 | Vossloh Hold | Warburg Research | |
| 04.11.25 | AXA Buy | Goldman Sachs Group Inc. | |
| 04.11.25 | Novartis Neutral | UBS AG | |
| 04.11.25 | HUGO BOSS Neutral | UBS AG | |
| 04.11.25 | Scout24 Neutral | UBS AG | |
| 04.11.25 | Schaeffler Neutral | UBS AG | |
| 04.11.25 | Rolls-Royce Buy | UBS AG | |
| 04.11.25 | Nemetschek Neutral | UBS AG | |
| 04.11.25 | Evonik Neutral | UBS AG | |
| 04.11.25 | Befesa Hold | Deutsche Bank AG | |
| 04.11.25 | WACKER CHEMIE Hold | Deutsche Bank AG | |
| 04.11.25 | GSK Hold | Deutsche Bank AG | |
| 04.11.25 | Ryanair Buy | Deutsche Bank AG | |
| 04.11.25 | SAF-HOLLAND Buy | Warburg Research | |
| 04.11.25 | WACKER CHEMIE Buy | Warburg Research | |
| 04.11.25 | Volkswagen Buy | Warburg Research | |
| 04.11.25 | Evonik Hold | Warburg Research | |
| 04.11.25 | BP Neutral | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.